Eppen_TracePCR_Dec24
  Editorial
 THE INDIAN PHARMACOPOEIA 2026   
 Wednesday, February 18, 2026 
 On January 2, 2026, the Indian Pharmacopoeia Commission (IPC) released the Indian Pharmacopoeia 2026 (IP-2026) which is the 10th edition of India’s official book of drug standards. IP-2026 contains a total 
  Past Editorial...  
TODAY'S NEWS
11:00  [IST]BD launches BD Vacutainer Urine Complete Cup Kit, a three-tube collection system to help clinicians improve diagnostic accuracy and efficiency
10:00  [IST]Cyprium Therapeutics inks agreement to sell rare paediatric disease priority review voucher for $205 million
09:00  [IST]Astellas and Vir Biotechnology collaborate to advance PSMA-targeting PRO-XTEN dual-masked T-cell engager VIR-5500 to treat prostate cancer
more news >>
TOP NEWS
08:00  [IST]SCDA requests Delhi drug regulator not to issue license to e-commerce, quick commerce drug sellers
08:00  [IST]DGFT rationalises RODTEP rates to boost pharma exports
08:00  [IST]Telangana drugs control administration launches public awareness campaign to combat AMR
08:00  [IST]PCI asks all pharmacy institutions to complete implementation of AEBAS before March 1
08:00  [IST]Andhra Pradesh launches massive digital overhaul of medicine supply chain
08:00  [IST]Health ministry amends list of MDTOs and tests to be conducted in designated laboratories
more news >>
YESTERDAY'S NEWS
17:35  [IST]Amrita unveils ‘MedSum’, AI tool to cut doctor paperwork and improve patient communication
17:25  [IST]Bayer expands Nubeqa in India as a treatment option without chemotherapy for men with metastatic hormone sensitive prostate cancer
17:15  [IST]Kiran Mazumdar-Shaw conferred honorary Fellowship of the Academy of Medical Sciences
16:40  [IST]Alembic Pharma receives US FDA final approval for efinaconazole topical solution
16:30  [IST]Dr Shroff’s Charity Eye Hospital in its centenary aims to invest in stem cell therapy, translational research
16:15  [IST]Aahwahan Foundation launches India’s first diabetic-free village initiative in Dharwad, Karnataka
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram